WASHINGTON - Not only is green tea the second most popular drink in the world, but it can also significantly reduce serum markers predictive of prostrate cancer progression.
James A. Cardelli, director of basic and translational research at the Feist-Weiller Cancer Centre, Louisiana said: “The investigational agent used in the trial, Polyphenon E may have the potential to lower the incidence and slow the progression of prostate cancer.”
The study included 26 men between the ages of 41 to 72 years, diagnosed with prostrate cancer. The patients were given four capsules containing Polyphenon E.
The results revealed that there was a significant reduction in serum levels after treatment.
Furthermore, results of a recent year-long clinical trial conducted in Italy revealed that consumption of green tea polyphenols reduced the risk of developing prostate cancer in men with high-grade prostrate intraepithelial neoplasia (HGPIN).
“These studies are just the beginning and a lot of work remains to be done. However, we think that the use of tea polyphenols alone or in combination with other compounds currently used for cancer therapy should be explored as an approach to prevent cancer progression and recurrence,” said Cardelli.
These results were published in Cancer Prevention Research, a journal of the American Association for Cancer Research.